A clinical study in AGHD to assess safety, tolerability and efficacy of GX-H9

Registry ID

EUCTR2014-002698-13

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Genexine, Inc

Start date

2015-01-14

Completion date

2016-12-30

Last update

2026-08-16

Conditions

• Adult Growth Hormone Deficiency (AGHD)

Summary

- To evaluate the change in insulin-like growth factor-1 (IGF-1) levels in relation to time and dose strengths

Locations

• , , Sweden
• , , Poland
• , , Greece
• , , Hungary
• , , Slovakia
• , , Germany

View on source registry